Biolab Farmacêutica disseminates knowledge to medical professionals at the SOCESP 2018 Conference

SINDUSFARMA | 05/30/2018
Leading Brazilian cardiovascular prescription medicine company Biolab Farmacêutica provides ongoing Medical Education to attendants at the XXXIX São Paulo State Cardiology Society Conference, featuring renowned panelists and workshops:

Extended Cardiovascular Continuum: Relationship between Atherosclerosis and Artery Age

May 31st, 12:50 P.M, Conference Room 7, Blue Sector.

Moderator: Dr. Francisco Fonseca, cardiology professor at the Escola Paulista de Medicina of Universidade Federal de São Paulo.

Panelists: Dr. Luiz Turatti, endocrinology doctor from the Medicine School of Universidade de São Paulo, and Dr. Oswaldo Kohlamnn Junior, associate Nephrology professor at the Escola Paulista de Medicina of Universidade Federal de São Paulo.

New Perspectives in Using Levosimendan

June 1st, 12:50 P.M, Conference Room 7, Blue Sector.

Panelists: Dr. Antônio Carlos Pereira Barretto, associate professor of the Medicine School at USP, talks about Levosimendan: evolution in its therapeutic application; Dr. Mucio Tavares, InCor emergency unit director, approaches the intermittent inotropic therapy in advanced heart failure; and Dr. Leopoldo Piegas debates evidences of using Levosimendan in heart surgery.

In addition to the Workshops, Biolab will feature a tradeshow booth where company representatives from all around the country will be available to address all attendees.

Clarification

The "Empresas em Foco" department publishes news created and sent by Sindusfarma member companies; said companies are fully responsible for the contents, which does not reflect any kind of concurrence, stances or opinions from the entity itself. (Portal Sindusfarma/SP – 05/29/2018)
Learn more
arrow_backward See more articles
Customer Service 0800 724 6522
faleconosco@biolabfarma.com.br
Be connected
Nós usamos cookies e outras tecnologias semelhantes para melhorar a sua experiência, personalizar publicidade e recomendar conteúdo de seu interesse. Ao navegar em nosso site, você está ciente de tal monitoramento. Para mais informações, consulte a nossa nova Política de Privacidade.